bpc 157 fda status not approved warning FDA's Overreach on Compounded Peptides fda warning bpc-157 peptide not
Description
The KCOA orthobiologics program consistently prevents unnecessary surgeries and eliminates pain through natural, safe, and effective treatments in the Kansas City area
The 0.25 mg dose is sub-therapeutic for weight loss in many people

So, my interest in LDN is re-ignited

The rationale is straightforward: a 120kg individual has significantly more tissue volume for the peptide to distribute through than a 70kg individual, which affects both the effective concentration at receptor sites and the perceived intensity of side effects
